article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry.

article thumbnail

ANDROMEDA Meta-Analysis: PCB Angioplasty vs. DES Implantation

American College of Cardiology

In patients undergoing PCI for de novo small-vessel coronary artery disease (SV-CAD), paclitaxel-coated balloon (PCB) angioplasty was associated with a reduction in the primary endpoint of major adverse cardiac events (MACE).

article thumbnail

Drug-Coated Balloons for the Treatment of CAD

JAMA Cardiology

This narrative review discusses drug-coated balloon angioplasty as an alternative to drug-eluting stent for percutaneous coronary intervention in patients with in-stent restenosis and de novo coronary artery disease.

article thumbnail

Submaximal Angioplasty for Severe Intracranial Atherosclerotic Stenosis: Benefit of Revascularization at Last

Stroke Journal

The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis.

article thumbnail

Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon

DAIC

Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. vs. 28.7%; P=0.006).

Stent 105
article thumbnail

Two-Year Clinical Outcomes in Female and Male Patients After Sirolimus-Coated Balloon Angioplasty for Coronary Artery Disease

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print.

article thumbnail

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte Image Guided Crossing and Re-Entry Catheter System

DAIC

This breakthrough device is poised to significantly change the approach to treating coronary CTOs by providing real-time optical coherence tomography (OCT) visualization, enabling precise guidewire placement within the target vessel's true lumen and subsequent revascularization.